Gerresheimer AG (ETR:GXI)
29.04
+1.10 (3.94%)
Oct 24, 2025, 5:35 PM CET
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 560.68M EUR in the quarter ending August 31, 2025, with 12.47% growth. This brings the company's revenue in the last twelve months to 2.25B, up 11.83% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.25B
Revenue Growth
+11.83%
P/S Ratio
0.45
Revenue / Employee
166.26K
Employees
12,142
Market Cap
1.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
| Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
| Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
| Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
| Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.68B |
| Fielmann Group AG | 2.40B |
Gerresheimer AG News
- 22 hours ago - Gerresheimer finds 2024 revenue-recognition issues after external probe - Reuters
- 1 day ago - Gerresheimer AG Probed for 2024 Revenue Practices - Wallstreet:Online
- 1 day ago - EQS-Adhoc: Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 financial year - Wallstreet:Online
- 12 days ago - EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 12 days ago - EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 12 days ago - EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy - Wallstreet:Online
- 13 days ago - EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU* - Wallstreet:Online
- 16 days ago - Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - GuruFocus